BPH - Benign Prostatic Enlargement - Results from #400

Clinical analysis of transurethral holmium laser enucleation in the treatment of benign prostatic hyperplasia with prostatic inflammation: A prospective research study. January 29, 2023

Ejaculatory Preserving Holmium Laser Enucleation of the Median Lobe: Preserving Sexual Function while Improving Urinary Outcomes. January 22, 2023

Contrast-enhanced magnetic resonance angiography in the identification of prostatic arterial anatomy in patients with benign prostatic hyperplasia: prospective comparison with digital subtraction angiography. January 22, 2023

Correlation Between Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms and Renal Function in Elderly Men Aged 80 Years and Older. January 22, 2023

Metabolic syndrome-related factors as possible targets for lower urinary tract symptoms in Korean males. January 16, 2023

Controversies in Prostate Artery Embolization: Future Best Practice. January 16, 2023

Quality Indicators in the Clinical Specialty of Urology: A Systematic Review. January 16, 2023

Holmium laser enucleation of a 696 cc prostate (HoLEP): The largest reported in the literature. January 16, 2023

Effect of urinary retention on the surgical outcome of holmium laser enucleation of the benign prostatic hyperplasia. January 15, 2023

Observation of complications assessed by Clavien-Dindo classification in different endoscopic procedures of benign prostatic hyperplasia: An observational study. January 15, 2023

Maximum Voided Volume Is a Better Clinical Parameter for Bladder Capacity Than Maximum Cystometric Capacity in Patients With Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: A Prospective Cohort Study. January 9, 2023

Lifestyle habits to prevent the development of benign prostatic hyperplasia: Analysis of Japanese nationwide datasets. January 9, 2023

Differential diagnosis of prostate cancer and benign prostatic hyperplasia based on DCE-MRI using bi-directional CLSTM deep learning and radiomics. January 9, 2023

DCE-MRI and DWI can differentiate benign from malignant prostate tumors when serum PSA is ≥10 ng/ml. January 9, 2023

Risk Analysis of Prostate Cancer Development Following Five-alpha Reductase Inhibitor Treatment for Benign Prostate Hyperplasia. January 9, 2023

Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide. January 3, 2023

Localization and potential role of prostate microbiota. January 2, 2023

Improving Prostatic Preoperative Volume Estimation and Planning before Laser Enucleation. January 2, 2023

Updates on Preprocedural Evaluation and Patient Selection for Prostatic Artery Embolization. December 26, 2022

Persistence to Medications for Benign Prostatic Hyperplasia/Benign Prostatic Obstruction-Associated Lower Urinary Tract Symptoms in the ASL TO4 Regione Piemonte (Italy). December 26, 2022

Page 21 of 140